Key stats
About IMBDX
Sector
Industry
Headquarters
Seoul
Website
Founded
2018
ISIN
KR7461030009
FIGI
BBG01LCGCWD5
IMBdx, Inc. engages in the development of liquid biopsy tests for cancer diagnosis. It focuses on the following business areas: diagnosis and treatment of advanced cancer, early detection of recurrence after surgery, and early cancer diagnosis. Its products include AlphaLiquid, CancerDetect, and CancerFind. The company was founded by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 461030 is 17050 KRW — it has decreased by 7.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange IMBDX stocks are traded under the ticker 461030.
461030 stock is 8.61% volatile and has beta coefficient of 3.55. Check out the list of the most volatile stocks — is IMBDX there?
461030 stock has fallen by 9.64% compared to the previous week, the month change is a 40.28% fall, over the last year IMBDX has showed a 40.28% decrease.
No, 461030 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 461030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMBDX stock right from TradingView charts — choose your broker and connect to your account.